Gene · 3108
Papers2,126
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,126
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crystal structures of MHC class I complexes reveal the elusive intermediate conformations explored during peptide editing. | Nat Commun | 2023 | 37596268 | PubTator, text mining | PubMed |
| Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer. | NPJ Breast Cancer | 2023 | 37582853 | PubTator, text mining | PubMed |
| Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37578930 | PubTator, text mining | PubMed |
| Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer. | Cancer Res Commun | 2023 | 37575280 | PubTator, text mining | PubMed |
| A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma. | Front Immunol | 2023 | 37575253 | PubTator, text mining | PubMed |
| Systemic immune response in young and elderly patients after traumatic brain injury. | Immun Ageing | 2023 | 37573338 | PubTator, text mining | PubMed |
| Structural Framework for Analysis of CD4+ T-Cell Epitope Dominance in Viral Fusion Proteins. | Biochemistry | 2023 | 37554055 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals T population heterogeneity and functions in tumor microenvironment of colorectal cancer metastases. | Heliyon | 2023 | 37539320 | PubTator, text mining | PubMed |
| Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma. | Front Pharmacol | 2023 | 37538176 | PubTator, text mining | PubMed |
| Structural and Functional Characterization of Drosophila melanogaster α-Amylase. | Molecules | 2023 | 37513201 | PubTator, text mining | PubMed |
| Prediction of Prognosis, Immunotherapy and Chemotherapy with an Immune-Related Risk Score Model for Endometrial Cancer. | Cancers (Basel) | 2023 | 37509334 | PubTator, text mining | PubMed |
| Identification of aging-related biomarkers and immune infiltration characteristics in osteoarthritis based on bioinformatics analysis and machine learning. | Front Immunol | 2023 | 37503333 | PubTator, text mining | PubMed |
| Autoimmune thyroid disease disrupts immune homeostasis in the endometrium of unexplained infertility women-a single-cell RNA transcriptome study during the implantation window. | Front Endocrinol (Lausanne) | 2023 | 37501789 | PubTator, text mining | PubMed |
| Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2. | PLoS Pathog | 2023 | 37498934 | PubTator, text mining | PubMed |
| The role of CD8+ T cells in endometriosis: a systematic review. | Front Immunol | 2023 | 37497226 | PubTator, text mining | PubMed |
| Tutorial: a statistical genetics guide to identifying HLA alleles driving complex disease. | Nat Protoc | 2023 | 37495751 | PubTator, text mining | PubMed |
| Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection. | Nat Commun | 2023 | 37468466 | PubTator, text mining | PubMed |
| The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy. | Biomed J | 2023 | 37467968 | PubTator, text mining | PubMed |
| Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine. | Front Immunol | 2023 | 37457721 | PubTator, text mining | PubMed |
| Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities. | Br J Cancer | 2023 | 37454231 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3108/papers?page=8